Memphasys Secures 1,000 Felix Cartridge Orders in MENA Markets
Key points
- Memphasys receives an additional order from ITL for 1,000 Felix cartridges
- Hamad Medical Corporation orders a second Felix console
- New orders include UAE, Kuwait, and Turkey
- 400 cartridges to be dispatched immediately, 600 in October 2026
Full summary
Memphasys Limited (ASX: MEM) announces a substantial order from International Technical Legacy (ITL) for 1,000 Felix cartridges, reflecting growing demand across the Middle East and North Africa (MENA) region. The order includes repeat purchases from Hamad Medical Corporation (HMC) in Qatar and new orders from the UAE and Kuwait. HMC's decision to order a second Felix console underscores its commitment to the technology. Memphasys expects additional orders from Turkey pending regulatory approval and anticipates further demand from other MENA markets. This order marks a significant milestone, with ITL's total confirmed orders reaching 1,800 cartridges, nearing their annual commitment of 2,500 cartridges.
Outlook
Memphasys and ITL anticipate continued growth in MENA markets, with key catalysts including the dispatch of 400 cartridges, Turkish regulatory approval, and ongoing pipeline development.
Summary generated by a large language model. Please interpret with care.